Back to Search
MARY JO MIDDLETON, M.D.
M.D.
Physical Medicine & Rehabilitation Physician
NPI: 1467553941IndividualAccepts Medicare
Specialties, Licenses & Credentials
Physical Medicine & Rehabilitation PhysicianPrimary
Physical Medicine & Rehabilitation
Code: 208100000X
MD100493(MO)
CMS Specialties
PrimaryPHYSICAL MEDICINE AND REHABILITATION
Education
UNIVERSITY OF MISSOURI, KANSAS CITY, SCHOOL OF MEDICINE
Class of 1987
Research & Publications (20)
Predicting the myelotoxicity of chemotherapy: the use of pretreatment O6-methylguanine-DNA methyltransferase determination in peripheral blood mononuclear cells.
PMID 19561552·Melanoma Res·2011
8-other
Societal preference values for advanced melanoma health states in the United Kingdom and Australia.
PMID 19603025·Br J Cancer·2009
8-other
A phase I study of extended dosing with lomeguatrib with temozolomide in patients with advanced melanoma.
PMID 19367282·Br J Cancer·2009
3-trial
O(6)-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatrib.
PMID 19367283·Br J Cancer·2009
4-observational
Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T.
PMID 19221054·Radiology·2009
8-other
Effect of PRESS and STEAM sequences on magnetic resonance spectroscopic liver fat quantification.
PMID 19557733·J Magn Reson Imaging·2009
3-trial
Structure and reactivity of TNT and related species: application of spectroscopic approaches and quantum-chemical approximations toward understanding transformation mechanisms.
PMID 19200649·J Hazard Mater·2009
8-other
Phase I pharmacokinetic and pharmacodynamic study of the prenyl transferase inhibitor AZD3409 in patients with advanced cancer.
PMID 18506143·Br J Cancer·2008
3-trial
A periodicity of approximately 1 hour in X-ray emission from the active galaxy RE J1034+396.
PMID 18800134·Nature·2008
8-other
Relaxation effects in the quantification of fat using gradient echo imaging.
PMID 18093781·Magn Reson Imaging·2008
8-other
Phase I study of the poly(ADP-ribose) polymerase inhibitor, AG014699, in combination with temozolomide in patients with advanced solid tumors.
PMID 19047122·Clin Cancer Res·2008
3-trial
Could sexually transmissible infections be contributing to the increase in HIV infections among men who have sex with men in Australia?
PMID 18588778·Sex Health·2008
8-other
A phase I trial of ispinesib, a kinesin spindle protein inhibitor, with docetaxel in patients with advanced solid tumours.
PMID 18319713·Br J Cancer·2008
3-trial
Practical guidelines for the management of interferon-alpha-2b side effects in patients receiving adjuvant treatment for melanoma: expert opinion.
PMID 18236459·Cancer·2008
6-review
A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer.
PMID 18475294·Br J Cancer·2008
3-trial
CD44 expressed on both bone marrow-derived and non-bone marrow-derived cells promotes atherogenesis in ApoE-deficient mice.
PMID 18420998·Arterioscler Thromb Vasc Biol·2008
7-preclinical
Phase I study of copper-binding agent ATN-224 in patients with advanced solid tumors.
PMID 19010871·Clin Cancer Res·2008
3-trial
Effects of intravenous gadolinium administration and flip angle on the assessment of liver fat signal fraction with opposed-phase and in-phase imaging.
PMID 18581393·J Magn Reson Imaging·2008
8-other
High-intensity focused ultrasound ablation of liver tumours: can radiological assessment predict the histological response?
PMID 18559903·Br J Radiol·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4801 E LINWOOD BLVD
KANSAS CITY, MO 64128 - Phone
- (816) 922-2740
Quick Facts
- NPI
- 1467553941
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 39
- Publications
- 20
Are you this provider?
Claim Your Profile